Lanxess Raises 2015 Profit Target After Beating Estimates

  • Ebitda ex-items expected to be EU860 million to EU900 million
  • Chemical maker to accelerate savings, become less cyclical

Lanxess AG, which is undergoing its biggest reorganization since Bayer AG carved out the chemical maker 10 years ago, raised its full-year profit forecast after quarterly earnings beat estimates and it accelerated a savings program.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.